Legal & General Group Plc - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 113 filers reported holding G1 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.83 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$6,319
-89.9%
2,358
-79.6%
0.00%
Q4 2022$62,831
-58.1%
11,571
-41.7%
0.00%
Q1 2022$150,000
-25.4%
19,837
+0.6%
0.00%
Q4 2021$201,000
+39.6%
19,727
+83.7%
0.00%
Q3 2021$144,000
+32.1%
10,741
+117.6%
0.00%
Q2 2021$109,000
-9.9%
4,936
-2.0%
0.00%
Q1 2021$121,000
+45.8%
5,036
+10.0%
0.00%
Q4 2020$83,000
+50.9%
4,580
-3.8%
0.00%
Q3 2020$55,000
-63.1%
4,761
-22.8%
0.00%
Q2 2020$149,000
+119.1%
6,168
+0.6%
0.00%
Q1 2020$68,000
-66.5%
6,130
-20.2%
0.00%
Q4 2019$203,000
+29.3%
7,679
+11.9%
0.00%
Q3 2019$157,000
-16.9%
6,861
+11.2%
0.00%
Q2 2019$189,000
+177.9%
6,172
+52.0%
0.00%
Q1 2019$68,000
-12.8%
4,0600.0%0.00%
Q4 2018$78,000
-55.9%
4,060
+20.0%
0.00%
Q3 2018$177,000
+25.5%
3,384
+4.1%
0.00%
Q2 2018$141,000
+60.2%
3,251
+36.1%
0.00%
Q1 2018$88,000
+151.4%
2,388
+35.7%
0.00%
Q4 2017$35,000
+9.4%
1,760
+34.9%
0.00%
Q3 2017$32,000
+966.7%
1,305
+695.7%
0.00%
Q2 2017$3,0001640.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
MPM BioImpact LLC 1,423,794$34,541,0009.18%
Burrage Capital Management LLC 373,876$9,070,0006.35%
Birchview Capital, LP 40,000$970,0000.59%
361 CAPITAL LLC 47,325$1,148,0000.54%
Rhenman & Partners Asset Management AB 190,000$4,609,0000.50%
CHI Advisors LLC 44,000$1,067,0000.42%
Bellevue Group AG 721,925$17,514,0000.25%
Candriam S.C.A. 870,423$21,117,0000.22%
Virtus ETF Advisers LLC 18,991$461,0000.22%
HHLR ADVISORS, LTD. 949,431$23,033,0000.21%
View complete list of G1 THERAPEUTICS INC shareholders